Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
AMANTA

Amanta Healthcare Share Price

 

 

Amanta Healthcare live price: ₹128.67. It opened at ₹124 vs previous close ₹121; intraday high/low: ₹132/₹119. The 50 DMA stands at ₹105.56.

Amanta Healthcare Performance

  • Today's Low
  • ₹119
  • Today's High
  • ₹132
  • 52 Week Low
  • ₹92
  • 52 Week High
  • ₹154
  • Open Price₹124
  • Previous Close₹121
  • Volume1,147,362
  • 50 DMA₹105.56
  • 100 DMA₹109.70
  • 200 DMA-

Amanta Healthcare Chart

Investment Returns

  • Over 1 Month + 34.41%
  • Over 3 Month + 20.64%
  • Over 6 Month + 3.51%
  • Over 1 Year + 2.12%

Smart Investing Starts Here Start SIP with Amanta Healthcare for Steady Growth!

Invest Now

Amanta Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 500
  • P/B Ratio
  • 2.3
  • Average True Range
  • 6.22
  • EPS
  • 4.11
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.23
  • RSI
  • 79.95
  • MFI
  • 89.41

Amanta Healthcare Financials

Amanta Healthcare Technicals

EMA & SMA

Current Price
₹128.67
+ 7.64 (6.31%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹108.25
  • 50 Day
  • ₹105.56
  • 100 Day
  • ₹109.70
  • 200 Day
  • -

Resistance and Support

126.46 Pivot Speed
  • R3 146.61
  • R2 139.16
  • R1 133.91
  • S1 121.21
  • S2 113.76
  • S3 108.51

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Amanta Healthcare is a midsize pharmaceutical company manufacturing sterile dosage forms, including IV fluids, irrigation solutions, ophthalmic and respiratory formulations, and small-volume injectables. With versatile facilities, it partners with leading pharma firms as a reliable contract manufacturer for global healthcare needs.

Amanta Healthcare Ltd has an operating revenue of Rs. 282.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of 5% is okay, ROE of 10% is good. The company has a high debt to equity of 126%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amanta Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-10 Quarterly Results
2025-11-11 Quarterly Results
2025-09-26 Quarterly Results

Amanta Healthcare F&O

Amanta Healthcare Shareholding Pattern

63.56%
3.99%
0.05%
1.1%
0%
16.91%
14.39%

Amanta Healthcare FAQs

Amanta Healthcare share price is ₹128 As on 17 April, 2026 | 03:30

The Market Cap of Amanta Healthcare is ₹499.6 Cr As on 17 April, 2026 | 03:30

The P/E ratio of Amanta Healthcare is 32.6 As on 17 April, 2026 | 03:30

The PB ratio of Amanta Healthcare is 2.3 As on 17 April, 2026 | 03:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23